An anti-BLyS biologic for lupus
Belimumab
A biologic for systemic lupus erythematosus that calms the immune cells driving the disease.
What is Belimumab?
Belimumab is a biologic medicine used for systemic lupus erythematosus (SLE), an autoimmune condition where the immune system attacks the body's own tissues. It blocks a protein called BLyS that helps certain immune cells survive, which reduces the overactive immune response behind lupus. It is given as a drip into a vein or as an injection under the skin. Because it affects the immune system it can raise the risk of infections, and it can affect mood, so any low mood or thoughts of self-harm should be reported.
Education and reference only. This is a plain-language guide to Belimumab — it deliberately contains no doses. Doses depend on the person, the brand and the reason for treatment, and belong with your prescriber. Always check the BNF, the product labelling (SmPC) and follow medical advice.
What it is
Belimumab is a biologic medicine, a laboratory-made antibody, used to treat active systemic lupus erythematosus (SLE), a long-term autoimmune condition, usually as an add-on to other lupus treatments. It is also used for lupus that affects the kidneys (lupus nephritis) in some people. It works by reducing the activity of B cells, the immune cells that make the antibodies driving lupus. It is given either as a drip into a vein or as an injection under the skin after training.
How it works
Belimumab blocks a protein called B-lymphocyte stimulator (BLyS, also known as BAFF), which helps B cells survive and mature. In lupus, overactive B cells produce antibodies that attack the body's own tissues, causing inflammation in the skin, joints, kidneys and elsewhere. By lowering BLyS, belimumab reduces the number of these troublesome B cells, calming the overactive immune response and easing disease activity over time. It works gradually as an add-on to standard lupus care.
Company & origin
Originated / developed by: GlaxoSmithKline.
A biologic medicine used in the UK for systemic lupus erythematosus (lupus), which works by calming part of the immune system that drives the disease.
Practical use
How to take Belimumab
General, dose-free guidance — always follow your prescriber's and the leaflet's specific instructions.
- It is given either as a drip into a vein at hospital or as an injection under the skin, which you or a carer can do at home after training.
- Continue your other lupus treatments as prescribed, as belimumab is added to standard care rather than replacing it.
- Report any signs of infection, such as fever or feeling generally unwell, without delay.
- Tell your team about any new or worsening low mood, anxiety or thoughts of harming yourself.
- Avoid live vaccines unless your specialist agrees, and tell other healthcare professionals you are on belimumab.
Weighing it up
Advantages & disadvantages of Belimumab
Advantages
- Can reduce lupus disease activity and flare-ups when added to standard treatment.
- May help reduce the need for steroids over time in some people.
- Available as both a hospital drip and a home injection under the skin.
Disadvantages
- Increases the risk of infections because it dampens the immune system.
- Has been linked to mood changes, including depression, in some people.
- Works gradually and is an add-on rather than a stand-alone cure.
Practical use
Good to know
Belimumab is a specialist treatment added to standard lupus care rather than replacing it, and it works gradually. Because it dampens part of the immune system, it can increase the risk of infections, so you should report signs of infection promptly. A particular point to be aware of is that mood changes, including depression and, rarely, thoughts of self-harm, have been reported, so tell your team about any new low mood or distressing thoughts. Infusion or injection reactions can happen, sometimes a little after the dose, so the first treatments may be observed. As with other immune-affecting biologics, live vaccines are generally avoided. Discuss pregnancy plans with your specialist, as your lupus treatment will be reviewed.
Who should not take it / use with caution
- People who have had a serious allergic reaction to belimumab should not have it again.
- It is used cautiously in people with a current serious infection, which should be treated first.
- It is generally used with caution in people with a history of severe depression, with close mental-health review.
Monitoring
- Watching for signs of infection before and during treatment.
- Checking mood and mental wellbeing, given the risk of depression.
- Reviewing lupus disease activity to judge whether it is helping.
Side effects
- Infections such as chest, urine or sinus infections, and nausea or diarrhoea.
- Infusion or injection reactions, sometimes occurring a little after the dose.
- Mood changes, including depression and, rarely, thoughts of self-harm.
Key interactions
- Avoid live vaccines while on treatment, as the immune response may be affected.
- It is usually used alongside other lupus medicines, so your overall treatment is balanced by your specialist.
- Combining it with other strong immune-suppressing biologics is generally avoided to limit infection risk.
Available as: Infusion into a vein, or injection under the skin (prefilled pen or syringe).
Answers
Belimumab: frequently asked questions
What is belimumab used for?
It is used for active systemic lupus erythematosus (lupus), and for lupus affecting the kidneys in some people, as an add-on to standard lupus treatment.
Will it cure my lupus?
No. It is not a cure but can reduce disease activity and flare-ups over time when added to your other lupus treatments.
Why should I report low mood?
Mood changes, including depression and, rarely, thoughts of self-harm, have been reported, so any new or worsening low mood or distressing thoughts should be told to your team.
Does it raise my infection risk?
Yes. Because it dampens part of the immune system, infections are more likely, so report any signs of infection promptly.
Can I have it as a home injection?
Yes, it can be given as an injection under the skin at home after training, as well as a hospital drip.
Authoritative sources
- BNF
- NICE CKS
Building a medicines information resource?
We create evidence-led, dose-free drug and formulary references for teams.